Overview

Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy

Status:
Completed

Trial end date:
2012-12-21

Target enrollment:

Participant gender:

Summary

This study is designed to demonstrate the efficacy and to assess the safety of cinacalcet for the reduction of hypercalcemia in patients with primary hyperparathyroidism for whom parathyroidectomy is indicated on the basis of an elevated corrected total serum calcium, but who are unable to undergo parathyroidectomy.

Phase:

Phase 3

Details

Lead Sponsor:

Amgen

Treatments:

Cinacalcet
Cinacalcet Hydrochloride